Lake Washington Vascular VenaSeal™ Post-Market Evaluation

NCT ID: NCT04146168

Last Updated: 2019-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

124 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-30

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

New-WAVES Study seeks to expand understanding/results from prior study (NCT02585726). Assessing both clinical outcomes and patient satisfaction after treatment with Venaseal/Cyanoacrylate Adhesive Closure System

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

New WAVES is an investigator initiated protocol that will assess clinical outcomes and patient satisfaction after treatment with VenaSeal(TM)/ Cyanoacrylate Adhesive Closure System 3 years post-treatment. All patients treated from a multi-provider practice, whom meet protocol inclusion criteria, will be invited to consider participation in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Varicose Veins Venous Reflux

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Venaseal cyanoacrylate closure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VenaSeal

Complete closure of previously treated veins will be assessed via ultrasound

Ultrasound

Intervention Type DIAGNOSTIC_TEST

Closure of previously treated veins (with Venaseal) will be assessed via ultrasound.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Closure of previously treated veins (with Venaseal) will be assessed via ultrasound.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Unilateral ultrasound of Limb

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Age ≥18 years; 2. Treatment of the great, small or accessory saphenous vein or any combination of saphenous veins with the Venaseal Closure System; 3. Treatment occurred at least 30 months prior to study; 4. Ability to understand the requirements of the study and to provide informed consent.

\-

Exclusion Criteria

1\. Subsequent treatment (such as laser or radiofrequency ablation) of venous disease in targeted vein segment after Venaseal closure; 2. Patients in whom index procedure information is unavailable; 3. Patients unwilling to undergo ultrasound evaluation and clinical examination of the previously treated limb; 4. Limbs that were treated in the VeClose trial (patients who participated in VeClose and later had contralateral limb treatment will be included).

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Vascular

INDUSTRY

Sponsor Role collaborator

Lake Washington Vascular

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kathleen Gibson, MD

Role: PRINCIPAL_INVESTIGATOR

Lake Washington Vascular, PLLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lake Washington Vascular

Bellevue, Washington, United States

Site Status RECRUITING

Lake Washington Vascular

Issaquah, Washington, United States

Site Status RECRUITING

Lake Washington Vascular

Kirkland, Washington, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kim D Glorieux, BS, BS, CCRC

Role: CONTACT

Phone: 425-453-1772

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kim Glorieux, BS, BS, CCRC

Role: primary

Kim Glorieux, BS, BS, CCRC

Role: primary

Kim Glorieux, BS, BS, CCRC

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-02

Identifier Type: -

Identifier Source: org_study_id